Position in NVAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$838,803
+$193,945 QoQ
Shares Held
89,045
+12.4% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 263 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,145,499 across 249 Biotechnology names. NVAX ranks #92 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in NVAX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $838,803 | 89,045 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $644,858 | 79,221 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $541,228 | 80,540 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $789,923 | 91,110 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $573,993 | 91,110 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $570,695 | 89,032 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $751,313 | 93,447 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,032,148 | 81,722 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,034,600 | 81,722 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $279,615 | 58,497 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $220,886 | 46,018 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $333,170 | 46,018 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $341,913 | 46,018 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $36,049 | 5,202 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $48,490 | 4,717 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $88,106 | 4,841 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $248,818 | 4,838 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $359,191 | 4,877 | Shares | Defined | 2024-05-10 | |
| 2021-03-31 | $4,096,155 | 22,592 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $2,737,124 | 24,546 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $2,776,252 | 25,623 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 | $2,135,677 | 25,623 | Shares | Defined | 2024-05-24 | |
| 2020-03-31 | $200,916 | 14,795 | Shares | Defined | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||